IGC Pharma, Inc., a clinical stage pharmaceutical company, develops novel therapeutic candidates for neuropsychiatric and neurodegenerative disorders, with a primary focus on Alzheimer's disease in the United States and Colombia. The company's lead product is IGC-AD1 that is in Phase II clinical trial for the treatment of agitation in dementia due to Alzheimer's. Its pre-clinical stage product candidate includes TGR-63 and IGC-M3 to treat Alzheimer's disease. In addition, the company develops MINT-AD, an AI-driven assistant for healthcare providers. The company was formerly known as India Globalization Capital, Inc. and changed its name to IGC Pharma, Inc. in March 2023. IGC Pharma, Inc. was incorporated in 2005 and is headquartered in Potomac, Maryland.
Frequently asked questions
What sector does India Globalization Capital Inc (IGC) operate in?
India Globalization Capital Inc belongs to the Industrials sector and operates in the Biotechnology industry.
What is India Globalization Capital Inc (IGC) current stock price?
As of the latest data, India Globalization Capital Inc stock price is $0.25, with a previous close of $0.25. India Globalization Capital Inc gained $0.00 in the last trading session, representing a 1.63% increase.
What is India Globalization Capital Inc (IGC) current market capitalization?
India Globalization Capital Inc market cap is approximately 25.85 million.
What is India Globalization Capital Inc (IGC) Earnings Per Share (EPS)?
The trailing EPS is -$0.06, and the forward EPS is -$0.09.
What is India Globalization Capital Inc (IGC) EBITDA?
India Globalization Capital Inc EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is -2.73 million.
Does India Globalization Capital Inc (IGC) pay dividends?
No. India Globalization Capital Inc does not pay a dividend.
How did India Globalization Capital Inc (IGC) perform in its most recent earnings report?
In the last report (June 30, 2026), India Globalization Capital Inc posted an EPS surprise of -50% and a revenue surprise of 61.59%.
When is India Globalization Capital Inc (IGC) next earnings report?
India Globalization Capital Inc is expected to release its next earnings report on September 30, 2026.
What is India Globalization Capital Inc (IGC) beta (volatility) score?
India Globalization Capital Inc has a beta of 0.491, indicating lower volatility than the overall market.
